Streptococcal infections: Race to multidrug resistance-A review

Rihana Begum Patnool Thirumoorthy Vithya Ashish Wadhwani V. Balasubramaniam Sivasankaran Ponnusankar   

Open Access   

Published:  Apr 23, 2022

DOI: 10.7324/JAPS.2022.120901
Abstract

According to the World Health Organization, the bacterial resistance to antimicrobial drugs has emerged as one of the major universal problems that requires and needs prime attention by humankind due to the emerging resistant acquired by many of the bacterial species which allows them to evade both antimicrobial drugs and the immune system. Streptococcus species (e.g., Streptococcus pneumonia, Streptococcus agalactiae, and Streptococcus pyogenes) are categorized serologically and are grounded on carbohydrates present in the cell wall into different groups, such as Group A to Group V. There are over 85 capsule antigenic types of S. pneumoniae, 124 serotypes of S. pyogenes, and 9 S. agalactiae with capsular polysaccharide serotypes (CPS). The primary cause for the failure of treatment for streptococcal infections is the enhanced resistance to antimicrobial drugs. Recently, infections caused by Streptococci resistant to multiple drugs have been increasing with a substantial affect to public health. Among Streptococcus species, drug resistance develops due to the excessive use of antibiotics. Streptococcus strains are also known as biofilm markers. The improved resistance of biofilms to antimicrobials among Streptococcus species stimulates persistent infection, which includes around 80% of bacterial infections in people. This review mainly focuses on the problem concerning Streptococcus species that is categorized and prioritized by the WHO.


Keyword:     Antibiotic resistance antimicrobial drugs multidrug resistance Streptococcus species GAS.


Citation:

Patnool RB, Vithya T, Wadhwani A, Balasubramaniam V, Ponnusankar S. Streptococcal infections: Race to multidrug resistance-A review. J Appl Pharm Sci, 2022. doi: https://doi.org/10.7324/JAPS.2022.120901

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Alves-Barroco C, Rivas-García L, Fernandes AR, Baptista PV. Tackling multidrug resistance in Streptococci-From novel biotherapeutic strategies to nanomedicines. Front Microbiol, 2020; 11:579916. https://doi.org/10.3389/fmicb.2020.579916

Angeletti S, Dicuonzo G, Avola A, Crea F, Dedej E, Vailati F, Farina C, De Florio L. Viridans Group Streptococci clinical isolates: MALDI-TOF mass spectrometry versus gene sequence-based identification. PLoS One, 2015; 10(3):e0120502. https://doi.org/10.1371/journal.pone.0120502

Anon, Flesh-eating bacteria thrive on pain. Nature, 2018; 557(7705):283. https://doi.org/10.1038/d41586-018-05137-6

Arsene MMJ, Jorelle ABJ, Sarra S, Viktorovna PI, Davares AKL, Ingrid NKC, Steve AAF, Andreevna SL, Yashina NV, Carime BZ. Short review on the potential alternatives to antibiotics in the era of antibiotic resistance. J Appl Pharm Sci, 2022; 12(01):029-40.

Balm MND, Truong HT, Choudhary AS, Robinson GM, Blackmore TK. Streptococcus gallinaceus bacteraemia in an abattoir worker presenting with a febrile illness. J Medi Microbiol, 2006; 55(7), 957-9. https://doi.org/10.1099/jmm.0.46546-0

Barnham M, Cole G, Efstratiou A, Tagg JR, Skjold SA. Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidemiol Infect, 1987; 98(2):171-82. https://doi.org/10.1017/S0950268800061884

Basak S, Singh P, Rajurkar M. Multidrug resistant and extensively drug resistant bacteria: a study. J Pathog, 2016; 2016:4065603. https://doi.org/10.1155/2016/4065603

Beighton D, Carr AD, Oppenheim BA. Identification of viridans streptococci associated with bacteraemia in neutropenic cancer patients. J Medi Microbiol, 1994; 40(3):202-4. https://doi.org/10.1099/00222615-40-3-202

Bert F, Lancelin MB, Zechovsky NL. Clinical significance of bacteremia involving the "Streptococcus milleri" group: 51 cases and review. Clin Infec Dis, 1998; 27(2):385-7. https://doi.org/10.1086/514658

Berwal A, Chawla K, Shetty S, Gupta A. Trend of antibiotic susceptibility of Streptococcus pyogenes isolated from respiratory tract infections in tertiary care hospital in south Karnataka. Iran J Microbiol. 2019; 11(1):13-8. https://doi.org/10.18502/ijm.v11i1.698

Bochud PY, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med, 1994; 97(3):256-64. https://doi.org/10.1016/0002-9343(94)90009-4

Bordes-Benitez A, Sanchez-Onoro M, Suárez-Bordón P, GarcíaRojas AJ, Saéz-Nieto JA, González-García A, Bolaños-Rivero M. Outbreak of Streptococcus equi subsp. zooepidemicus infections on the island of Gran Canaria associated with the consumption of inadequately pasteurized cheese. Eur J Clin Microbiol Infect Dis, 2006; 25(4):242-6. https://doi.org/10.1007/s10096-006-0119-x

Boyer K. National Institute of Environmental Health Sciences (NIEHS). Encyclopedia of Global Health [Internet]. SAGE Publications, Inc., 2008.

Brook I. Penicillin failure in the treatment of Streptococcal pharyngo-tonsillitis. Curr Infect Dis Rep, 2013; 15(3):232-5. https://doi.org/10.1007/s11908-013-0338-0

Brouwer S, Barnett TC, Rivera-Hernandez T, Rohde M, Walker MJ. Streptococcus pyogenes adhesion and colonization. FEBS Lett, 2016; 590(21):3739-57. https://doi.org/10.1002/1873-3468.12254

Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis, 2005; 5(11):685-94. https://doi.org/10.1016/S1473-3099(05)70267-X

Cartwright K. Group A streptococcal infections in humans. J Appl Microbiol, 1997; 83(S1):52S-61S. https://doi.org/10.1046/j.1365-2672.83.s1.6.x

Chadfield MS, Christensen JP, Decostere A, Christensen H, Bisgaard M. Geno-and phenotypic diversity of avian isolates of Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis) and associated diagnostic problems. J Clin Microbiol, 2007; 45(3):822-7. https://doi.org/10.1128/JCM.00922-06

Chang W, Wu J, Huang C, Tsai Y, Chien C, Lu C. Identification of viridans streptococcal species causing bacterial meningitis in adults in Taiwan. Eur J Clin Microbiol Infect Dis, 2002; 21(5):393-6. https://doi.org/10.1007/s10096-002-0727-z

Chawla K, Gurung B, Mukhopadhyay C, Bairy I. Reporting emerging resistance of Streptococcus pneumoniae from India. J Glob Infect Dis, 2010; 2(1):10. https://doi.org/10.4103/0974-777X.59245

Chun S, Huh HJ, Lee NY. Species-specific difference in antimicrobial susceptibility among viridans group streptococci. Ann Lab Med, 2015; 35(2):205-11. https://doi.org/10.3343/alm.2015.35.2.205

Clarridge JE, Attorri S, Musher DM, Hebert J, Dunbar S. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri Group") are of different clinical importance and are not equally associated with abscess. Clin Infect Dis, 2001; 32(10):1511-5. https://doi.org/10.1086/320163

Cohen ML. Changing patterns of infectious disease. Nature, 2000; 406(6797):762-7. https://doi.org/10.1038/35021206

Cole JN, Henningham A, Gillen CM, Ramachandran V, Walker MJ. Human pathogenic streptococcal proteomics and vaccine development. Proteomics-Clin App, 2008; 2(3):387-410. https://doi.org/10.1002/prca.200780048

Collignon PJ, Bell JM. Australian Group on Antimicrobial Resistance (AGAR). Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Med J Aust, 1996; 164(2), 64-67. https://doi.org/10.5694/j.1326-5377.1996.tb101349.x

Cunliffe N. Jacob A. Bacteraemia. J Infect, 1997; 34(1):85. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev, 2000; 13(3):470-511. https://doi.org/10.1128/CMR.13.3.470

Davis CP. Normal flora. Medical Microbiology, 4th edition, University of Texas Medical Branch, Galveston, TX, 1996.

Divya MJ, Vijey AM. An overview on antibiotic use and resistance. Res J Pharm Tech, 2017; 10(8):2793-6. https://doi.org/10.5958/0974-360X.2017.00494.2

Douglas CWI, Heath J, Hampton KK, Preston FE. Identity of viridans streptococci isolated from cases of infective endocarditis. J Med Microbiol, 1993; 39(3):179-82. https://doi.org/10.1099/00222615-39-3-179

Doyuk E, Ormerod OJ, Bowler I. Native valve endocarditis due to Streptococcus vestibularis and Streptococcus oralis. J Infect, 2002; 45(1):39-41. https://doi.org/10.1053/jinf.2002.1004

Ellmerich S, Scholler M, Duranton B, Gosse F, Galluser M, Klein JP, Raul F. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis, 2000; 21(4):753-6. https://doi.org/10.1093/carcin/21.4.753

Facklam R, Elliott J, Pigott N, Franklin AR. Identification of Streptococcus porcinus from human sources. J Clin Microbiol, 1995; 33(2):385-8. https://doi.org/10.1128/jcm.33.2.385-388.1995

Facklam RF, Martin DR, Marguerite L, Dwight RJ, Efstratiou A, Thompson T, Gowan S, Kriz P, Tyrrell GJ, Kaplan E, Beall B. Extension of the lancefield classification for group A Streptococci by addition of 22 new m protein gene sequence types from clinical isolates: emm103 to emm124. Clin Infect Dis, 2002; 34(1);28-38. https://doi.org/10.1086/324621

Farley MM, Strasbaugh LJ. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis, 2001; 33(4):556-61. https://doi.org/10.1086/322696

Finkelstein Y, Marcus N, Mosseri R, Bar-Sever Z, Garty BZ. Streptococcus acidominimus infection in a child causing Gradenigo syndrome. Int J Pedi Otorhinolaryngol, 2003; 67(7):815-7. https://doi.org/10.1016/S0165-5876(03)00088-0

Francis AJ, Nimmo GR, Efstratiou A, Galanis V, Nuttall N. Investigation of milk-borne Streptococcus zooepidemicus infection associated with glomerulonephritis in Australia. J Infect, 1993; 27(3):317- 23. https://doi.org/10.1016/0163-4453(93)92358-4

Galpérine T, Cazorla C, Blanchard E, Boineau F, Ragnaud JM, Neau D. Streptococcus canis infections in humans: retrospective study of 54 patients. J Infect, 2007; 55(1):23-6. https://doi.org/10.1016/j.jinf.2006.12.013

Gavin PJ, Thomson RB, Horng SJ, Yogev R. Neonatal sepsis caused by Streptococcus bovis variant (Biotype II/2): report of a case and review. J Clin Microbiol, 2003; 41(7):3433-5. https://doi.org/10.1128/JCM.41.7.3433-3435.2003

Gerber JS, Glas M, Frank G, Shah SS. Streptococcus bovis Infection in Young Infants. Ped Infect Dis J, 2006; 25(11):1069-73. https://doi.org/10.1097/01.inf.0000240334.91713.48

Gillespie S. Failure of penicillin in Streptococcus pyogenes pharyngeal infection. Lancet, 1998; 352(9145):1954-6. https://doi.org/10.1016/S0140-6736(05)61327-X

Golden AR, Baxter MR, Davidson RJ, Martin I, Demczuk W, Mulvey MR, Karlowsky JA, Hoban DJ, Zhanel GG, Adam HJ. Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007-16. J Antimicro Chemo, 2019; 1;74(Supplement_4):iv39-47. https://doi.org/10.1093/jac/dkz286

Goyal R, Singh NP, Kaur M, Talwar V. Antimicrobial resistance in invasive and colonising Streptococcus pneumoniae in North India. Ind J Med Microbiol, 2007; 25(3):256-9. https://doi.org/10.1016/S0255-0857(21)02117-4

Goyette-Desjardins G, Auger JP, Xu J, Segura M, Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg Microbes Infect, 2014; 3(1):1-20. https://doi.org/10.1038/emi.2014.45

Han XY, Kamana M, Rolston KVI, Viridans Streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. J Clin Microbiol, 2006; 44(1):160-5. https://doi.org/10.1128/JCM.44.1.160-165.2006

Hashikawa S, Iinuma Y, Furushita M, Ohkura T, Nada T, Torii K, Hasegawa T, Ohta M. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol, 2004; 42(1):186-92. https://doi.org/10.1128/JCM.42.1.186-192.2004

Hayes CS, Williamson Jr HA. Management of group A betahemolytic streptococcal pharyngitis. Am Fam Phys, 2001; 63(8):1557.

Herzberg MC, Meyer MW, Kiliç A, Tao L. Host-pathogen interactions in bacterial endocarditis: streptococcal virulence in the host. Adv Dent Rese, 1997; 11(1):69-74. https://doi.org/10.1177/08959374970110011901

High KP, Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis, 2005; 41(6):839-47. https://doi.org/10.1086/432804

Huang YT. Teng LJ. Ho SW. Hsueh PR. Streptococcus suis infection. J Microbiol Imm Infect. 2005; 38(5):306-13.

Ishida T, Maniwa K, Kagioka H, Hirabayashi M, Tomioka H, Hayashi M, Tomii K, Gohma I, Ito Y, Hirai T, Ito I, Mishima M. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Respirology, 2008; 13(2):240-6. https://doi.org/10.1111/j.1440-1843.2007.01214.x

Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, Rappuoli R. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol, 2006; 4(12):932-42. https://doi.org/10.1038/nrmicro1552

Jonsson P, Olsson SO, Olofson AS, Fälth C, Holmberg O, Funke H. Bacteriological investigations of clinical mastitis in heifers in Sweden. J Dairy Res, 1991; 58(2):179-85. https://doi.org/10.1017/S0022029900029721

Kanungo R, Rajalakshmi B. Serotype distribution & antimicrobial resistance in Streptococcus pneumoniae causing invasive & other infections in south India. Ind J Med Res, 2001; 114:127.

Kebede D, Admas A, Mekonnen D. Prevalence and antibiotics susceptibility profiles of Streptococcus pyogenes among pediatric patients with acute pharyngitis at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia. BMC Microbiol, 2021; 21(1):1-10. https://doi.org/10.1186/s12866-021-02196-0

Klein RS, Catalano MT, Edberg SC, Casey JI. Streptococcus equinus septicemia: report of two cases and review of the literature. Am J Med Sci, 1980; 279(2):99-103. https://doi.org/10.1097/00000441-198003000-00003

Lalitha M, Pai R, Manoharan A. Multidrug-resistant Streptococcus pneumoniae from India. Lancet, 2002; 359(9304):445. https://doi.org/10.1016/S0140-6736(02)07578-5

Lau SKP, Woo PCY, Luk W, Fung AMY, Hui WT, Fong AH, Chow CW, Wong SS, Yuen KY. Clinical isolates of Streptococcus iniae from Asia are more mucoid and β-hemolytic than those from North America. Diag Microbiol Infect Dis, 2006; 54(3):177-81. https://doi.org/10.1016/j.diagmicrobio.2005.09.012

Le Bouguenec C, De Cespedes G, Horaud T. Presence of chromosomal elements resembling the composite structure Tn3701 in streptococci. J Bacteriol, 1990; 172(2):727-34. https://doi.org/10.1128/jb.172.2.727-734.1990

Le Doare K, O'Driscoll M, Turner K, Seedat F, Russell NJ, Seale AC, Heath PT, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Kampmann B; GBS Intrapartum Antibiotic Investigator Group. Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review. Clin Infect Dis, 2017; 65(suppl_2):S143-51. https://doi.org/10.1093/cid/cix654

Leonardo A, Sechi RC. Streptococcus equinus endocarditis in a patient with pulmonary histiocytosis X. Scand J Infect Dis, 1999; 31(6), 598-600. https://doi.org/10.1080/00365549950164526

Lim LH, Lee WS, Parasakthi N. Childhood invasive pneumococcal disease: A hospital-based study from Malaysia. J Pead Child Health, 2007; 43(5):366-9. https://doi.org/10.1111/j.1440-1754.2007.01081.x

Luepke KH, Suda KJ, Boucher H, Russo RL, Bonney MW, Hunt TD, Mohr JF. Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications. Pharmacotherapy: J Hum Pharmacal Drug Ther, 2016; 37(1), 71-84. https://doi.org/10.1002/phar.1868

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect, 2012; 18(3):268- 81. https://doi.org/10.1111/j.1469-0691.2011.03570.x

Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. J Pediatr, 1993; 123(5):679-85. https://doi.org/10.1016/S0022-3476(05)80840-6

Martin C, Fermeau V, Eyraud JL, Aubard Y. Streptococcus porcinus as a Cause of spontaneous preterm human stillbirth. J Clin Microbiol, 2004; 42(9):4396-8. Mitchell TJ. The pathogenesis of streptococcal infections: from Tooth decay to meningitis. Nature Rev Microbiol, 2003; 1(3):219-30. https://doi.org/10.1128/JCM.42.9.4396-4398.2004

Morales E, Cots F, Sala M, Comas M, Belvis F, Riu M, Castells X. Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. BMC Health Ser Res, 2012; 12(1):122. https://doi.org/10.1186/1472-6963-12-122

Mulholland K. Strategies for the control of pneumococcal diseases. Vaccine, 1999; 17:S79-84. https://doi.org/10.1016/S0264-410X(99)00112-7

Nobbs AH, Lamont RJ, Jenkinson HF. Streptococcus adherence and colonization. Microbiol Mol Biol Rev, 2009; 73(3):407-50. https://doi.org/10.1128/MMBR.00014-09

Orand JP. Antimicrobial resistance and the standards of the World Organisation for Animal Health. Rev Scient Tech (Int Off Epizootics), 2012; 31(1):335-42. https://doi.org/10.20506/rst.31.1.2120

Orihuela CJ, Tuomanen EI. Models of pneumococcal disease. Drug Disc Today: Dis Models, 2006; 3(1):69-75. https://doi.org/10.1016/j.ddmod.2006.03.001

Patterson MJ. Streptococcus. Med Microbiol, 4th edition, 1996. Pelluri R, Monika P, Paritala H, Annapareddy CR, Kotha B, Meenavilli S, Angadi SR, Rayapati G, Puttagunta S. Antibiotics susceptibility pattern and prevalence of isolated uropathogens in inpatient and out patients with lower urinary tract infections. J Appl Pharm Sci, 2022; 12(01):159-64.

Rihana BP, Wadhwani A, Balasubramaniam V, Ponnusankar S, Need for the implementation of antibiotic policy in India: An Overview. Int J Cur Res Rev, 2021; 13(05):168-78. https://doi.org/10.31782/IJCRR.2021.13511

Rojo-Bezares B, Toca L, Azcona-Gutiérrez JM, Ortega-Unanue N, Toledano P, Sáenz Y. Streptococcus dysgalactiae subsp. equisimilis from invasive and non-invasive infections in Spain: combining epidemiology, molecular characterization, and genetic diversity. Eur J Clin Microbiol Infect Dis, 2021; 40(5):1013-21. https://doi.org/10.1007/s10096-020-04119-9

Rosenberger LH, Hranjec T, Politano AD, Swenson BR, Metzger R, Bonatti H, Sawyer RG. Effective Cohorting and "Superisolation" in a single intensive care unit in response to an outbreak of diverse multi-drugresistant organisms. Surg Infect, 2011; 12(5):345-50. https://doi.org/10.1089/sur.2010.076

Schlegel L, Grimont F, Collins MD, Regnault B, Grimont PA, Bouvet A. Streptococcus infantarius sp. nov., Streptococcus infantarius subsp. infantarius subsp. nov. and Streptococcus infantarius subsp. coli subsp. nov., isolated from humans and food. Int J Syst Evol Microbiol, 2000; 50(4):1425-34. https://doi.org/10.1099/00207713-50-4-1425

Schuchat A. Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms. Clin Microbiol Rev, 1998; 11(3):497-513. https://doi.org/10.1128/CMR.11.3.497

Segura M, Calzas C, Grenier D, Gottschalk M. Initial steps of the pathogenesis of the infection caused by Streptococcus suis: fighting against nonspecific defenses. FEBS Lett, 2016; 590(21):3772-99. https://doi.org/10.1002/1873-3468.12364

Sharma A. Antimicrobial resistance: no action today, no cure tomorrow. Ind J Med Microbiol, 2011; 29(2):91-2. https://doi.org/10.4103/0255-0857.81774

Sharma A, Arya DK, Sagar V, Bergmann R, Chhatwal GS, Johri AK. Identification of potential universal vaccine candidates against group A Streptococcus by using high throughput in silico and proteomics approach. J Proteomic Res, 2012; 12(1):336-46. https://doi.org/10.1021/pr3005265

Shet A, Ferrieri P, Neonatal & maternal group B streptococcal infections: a comprehensive review. Ind J Med Res, 2004; 120:141-50.

Simoni S, Vincenzi C, Brenciani A, Morroni G, Bagnarelli P, Giovanetti E, Varaldo PE, Mingoia M. Molecular characterization of Italian isolates of fluoroquinolone-resistant Streptococcus agalactiae and relationships with chloramphenicol resistance. Micro Drug Resist, 2018; 24(3):225-31. https://doi.org/10.1089/mdr.2017.0139

Straume D, Stamsås GA, Håvarstein LS. Natural transformation and genome evolution in Streptococcus pneumoniae. Infect Genet Evol 2015; 33: 371-80. https://doi.org/10.1016/j.meegid.2014.10.020

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis, 2018; 18(3):318-27. https://doi.org/10.1016/S1473-3099(17)30753-3

Teare EL, Smithson RD, Efstratiou A, Devenish WR, Noah ND. An outbreak of puerperal fever caused by group C streptococci. J Hosp Infect, 1989; 13(4):337-47. https://doi.org/10.1016/0195-6701(89)90053-4

Teng LJ, Hsueh PR, Ho SW, Luh KT. High Prevalence of Inducible Erythromycin Resistance among Streptococcus bovis Isolates in Taiwan. Antimicrob Agents Chemother, 2001; 45(12):3362-5. https://doi.org/10.1128/AAC.45.12.3362-3365.2001

Thomas K, Group IBISI, Network ICE. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Lancet, 1999; 353(9160):1216-21. https://doi.org/10.1016/S0140-6736(98)07228-6

Toit M du, Huch M, Cho GS, Franz CMAP. The family Streptococcaceae. Lactic Acid Bact, 2014; 445-6. https://doi.org/10.1002/9781118655252.part6

Tripodi MF, Fortunato R, Utili R, Triassi M, Zarrilli R. Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients. Clin Microbiol Infect, 2005; 11(10):814-9. https://doi.org/10.1111/j.1469-0691.2005.01248.x

Van't Wout JW, Bijlmer HA. Bacteremia Due to Streptococcus gallolyticus, or the Perils of Revised Nomenclature in Bacteriology. Clin Infect Dis, 2005; 40(7):1070-1. https://doi.org/10.1086/428671

Wessman GE. Biology of the group E streptococci: a review. Vet Microbiol, 1986; 12(4):297-328. https://doi.org/10.1016/0378-1135(86)90081-7

Westling K. Ljungman P. Thalme A. Julander I. Streptococcus viridans Septicaemia: a comparison study in patients admitted to the Departments of Infectious Diseases and Haematology in a University Hospital. Scandinavian J Infect Dis, 2002; 34(4):316-9. https://doi.org/10.1080/00365540110077434

Whiley RA, Hall LMC, Hardie JM, Beighton D. A study of small-colony, β-haemolytic, Lancefield group C streptococci within the anginosus group: description of Streptococcus constellatus subsp. pharyngis subsp. nov., associated with the human throat and pharyngitis. Int J Sys Evol Microbiol, 1999; 49(4):1443-9. https://doi.org/10.1099/00207713-49-4-1443

Woo PC, Teng JL, Leung K, Lau SK, Tse H, Wong BH, Yuen K. Streptococcus sinensis may react with Lancefield group F antiserum. J Med Microbiol, 2004; 53(11):1083-8. https://doi.org/10.1099/jmm.0.45745-0

World Health Organization. Weekly Epidemiological Record. Relive épidémiologique hebdomadaire, 2013; 88(31):321-36.

Yuen KY, Seto WH, Choi CH, Ng W, Ho SW, Chau PY. Streptococcus zooepidemicus (Lancefield group C) septicaemia in Hong Kong. J Infect, 1990; 21(3):241-50. https://doi.org/10.1016/0163-4453(90)93885-V

Zapun A. Vernet T. Pinho MG. The different shapes of cocci. FEMS Microbiol Rev, 2008; 32(2):345-60. https://doi.org/10.1111/j.1574-6976.2007.00098.x

Article Metrics

3 Absract views 0 PDF Downloads 3 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required